Antiretroviral Drug-Drug Interaction Considerations for HIV-Infected Children

被引：2
|
作者：
Fletcher, Courtney V. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Coll Pharm, Omaha, NE USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2009年 / 28卷 / 05期
关键词：
Antiretrovirals; drug-drug interactions; HIV infection; children; THERAPY; PHARMACOKINETICS; RIFAMPICIN; INHIBITOR; EFAVIRENZ; PLASMA;
D O I：
10.1097/INF.0b013e3181a622bb
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：429 / 430
页数：2
相关论文
共 50 条
  • [41] Antiretroviral drug-drug interactions: A comparison of online drug interaction databases COMMENT
    Drwiega, Emily N.
    Badowski, Melissa E.
    Michienzi, Sarah
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (10) : 1720 - 1724
  • [42] The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?
    Whitlock, G. G.
    Patel, A.
    Edwards, S. G.
    Benn, P. D.
    Miller, R. F.
    [J]. CLINICAL MEDICINE, 2012, 12 (03): : 300 - 301
  • [43] Antiretroviral Drug Susceptibility Among HIV-Infected Adults Failing Antiretroviral Therapy in Rakai, Uganda
    Reynolds, Steven J.
    Laeyendecker, Oliver
    Nakigozi, Gertrude
    Gallant, Joel E.
    Huang, Wei
    Hudelson, Sarah E.
    Quinn, Thomas C.
    Newell, Kevin
    Serwadda, David
    Gray, Ronald H.
    Wawer, Maria J.
    Eshleman, Susan H.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (12) : 1739 - 1744
  • [44] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Arnsten, JH
    Demas, PA
    Grant, RW
    Gourevitch, MN
    Farzodegan, H
    Howard, AA
    Schoenboum, EE
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) : 377 - 381
  • [45] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Julia H. Arnsten
    Penelope A. Demas
    Richard W. Grant
    Marc N. Gourevitch
    Homayoon Farzadegan
    Andrea A. Howard
    Ellie E. Schoenbaum
    [J]. Journal of General Internal Medicine, 2002, 17 : 377 - 381
  • [46] No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients
    Schippers, EF
    Hugen, PWH
    den Hartigh, J
    Burger, DM
    Hoetelmans, RMW
    Visser, LG
    Kroon, FP
    [J]. AIDS, 2000, 14 (17) : 2794 - 2795
  • [47] Polypharmacy and Risk of Antiretroviral Drug Interactions Among the Aging HIV-Infected Population
    Carol Holtzman
    Carl Armon
    Ellen Tedaldi
    Joan S. Chmiel
    Kate Buchacz
    Kathleen Wood
    John T. Brooks
    [J]. Journal of General Internal Medicine, 2013, 28 : 1302 - 1310
  • [48] Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action
    Bazzoli, Caroline
    Jullien, Vincent
    Le Tiec, Clotilde
    Rey, Elisabeth
    Mentre, France
    Taburet, Anne-Marie
    [J]. CLINICAL PHARMACOKINETICS, 2010, 49 (01) : 17 - 45
  • [49] Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action
    Caroline Bazzoli
    Vincent Jullien
    Clotilde Le Tiec
    Elisabeth Rey
    France Mentré
    Anne-Marie Taburet
    [J]. Clinical Pharmacokinetics, 2010, 49 : 17 - 45
  • [50] Effect of therapeutic drug monitoring on outcome in antiretroviral experienced HIV-infected individuals
    Mallon, PWG
    Ray, J
    Cooper, DA
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2003, 26 (02) : 223 - 227
12345